Jersey Shore NJ
FDA Grants Orphan Drug Designation to Puma Biotechnology's NERLYNX for the Treatment of Breast Cancer Patients with Brain Metastases
LOS ANGELES--(BUSINESS WIRE)--Sep 3, 2019-- |!| Atlantic City
